"You don't have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care

Brynn Kosteniuk, Ginetta Salvalaggio, Ryan McNeil, Hannah L. Brooks, Kathryn Dong, Shanell Twan, Jennifer Brouwer, Elaine Hyshka
2021 International journal of drug policy  
Acute care hospitals have been described as a high risk environment for people who use drugs (PWUD). Formal and informal bans on drug use can lead patients to conceal their use and consume under unsafe circumstances. Provision of hospital-based supervised consumption services (SCS) could help reduce drug-related harms and improve patient care. However, no peer-reviewed research documents patient experiences with attending SCS in this setting. To address this gap, the present study examines key
more » ... actors that shape patients' decisions to attend or not attend a novel SCS embedded within a large, urban acute care hospital in Western Canada. We adopted a focused ethnographic design and conducted 28 semi-structured interviews with SCS-eligible patients. We examined participant accounts thematically, and Rhodes' "Risk Environment" framework helped guide our analysis. Most participants perceived the SCS as a safer environment that made it possible to reduce drug-related risks and avoid using in unsafe areas of the hospital where they could be caught by staff, security, or police. However, some participants did not trust that the SCS would provide adequate protection from criminalization, which motivated them to avoid the site. Several participants also worried about the potential for unwanted changes to their patient care following SCS use. Physical site and policy limitations, such as eligibility requirements and a lack of infrastructure to support supervised inhalation, were additional reasons for not attending the SCS. PWUD in this study attended the hospital-based SCS in an attempt to reduce risks associated with their hospital stay. However, we note a number of access barriers that should be addressed to ensure optimal uptake. Wider provision of SCS in acute care requires both changes to the hospital environment and broader drug policy reform.
doi:10.1016/j.drugpo.2021.103275 pmid:34020865 fatcat:3n57q33vrnaajar5kfzu6uvrsu